Evidence map›Paper›PMID 41614303›Full record

ArticleNucleic acids research2026

Separate transcription and splicing gene networks are linked and coordinated by the pRb-E2F pathway.

Simon M Carr, Geng Liu, Wojciech Barczak, Hasan Syffudin, Shonagh Munro, Denise Reyna-Jeldes, Iolanda Vendrell, Benedikt Kessler, Adam P Cribbs, Alexander Kanapin and 2 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Simon M CarrLaboratory of Cancer Biology, Department of Oncology, University of Oxford Old Road Campus Research Building, Oxford OX3 7DQ, United Kingdom.
Geng LiuLaboratory of Cancer Biology, Department of Oncology, University of Oxford Old Road Campus Research Building, Oxford OX3 7DQ, United Kingdom.
Wojciech BarczakLaboratory of Cancer Biology, Department of Oncology, University of Oxford Old Road Campus Research Building, Oxford OX3 7DQ, United Kingdom.
Hasan SyffudinLaboratory of Cancer Biology, Department of Oncology, University of Oxford Old Road Campus Research Building, Oxford OX3 7DQ, United Kingdom.
Shonagh MunroLaboratory of Cancer Biology, Department of Oncology, University of Oxford Old Road Campus Research Building, Oxford OX3 7DQ, United Kingdom.
Denise Reyna-JeldesLaboratory of Cancer Biology, Department of Oncology, University of Oxford Old Road Campus Research Building, Oxford OX3 7DQ, United Kingdom.
Iolanda VendrellTarget Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom.
Benedikt KesslerTarget Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom.
Adam P CribbsNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford OX3 7LD, United Kingdom.ORCID 0000-0001-5288-3077
Alexander KanapinDepartment of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, United Kingdom.
Anastasia SamsonovaDepartment of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, United Kingdom.
Nicholas B La ThangueLaboratory of Cancer Biology, Department of Oncology, University of Oxford Old Road Campus Research Building, Oxford OX3 7DQ, United Kingdom.ORCID 0000-0003-2568-3736

Funding

Cancer Research UK A20776Medical Research Council MR/V010182/1Science Foundation 23-14-00134University of Oxford
6 · The paper itself

Abstract

The pRb-E2F pathway is involved in mediating diverse cell fates, and oncogenic disruption of the pathway is regarded as a hallmark of cancer. Recent studies highlighted the pRb-E2F axis as a regulator of a large gene network which includes RNA splicing and transcription targets. Here, we have performed a deep genome-wide analysis of differentially expressed genes (DEGs) and alternatively spliced (AS) RNA targets which highlighted broadly non-overlapping networks of genes that are independently regulated by the pRb-E2F pathway. Individual pathway components, including E2F1, pRb, and PRMT5, either as single or combined knockouts, were found to influence DEG and AS networks but to different extents. An analysis of the E2F1 interactome revealed SRSF2 and HNRNPC as candidate proteins that were able to functionally assist E2F1 in mediating AS events. Moreover, E2F1 AS activity was evident as cells progress through the cell cycle and during the DNA damage response, and apparent in tumour models. Our results highlight gene networks where transcription and splicing are linked and coordinated by the pRb-E2F pathway, and further establish the widespread influence that pRb, E2F1, and PRMT5 have on regulating biological diversity through RNA splicing control.

Indexed as

Alternative SplicingE2F1 Transcription FactorGene Regulatory NetworksRetinoblastoma ProteinRNA SplicingTranscription, GeneticAnimalsE2F Transcription FactorsHumansProtein-Arginine N-MethyltransferasesSerine-Arginine Splicing FactorsSignal TransductionE2F1 protein, humanE2F1 Transcription FactorE2F Transcription FactorsProtein-Arginine N-MethyltransferasesRetinoblastoma ProteinSerine-Arginine Splicing FactorsSRSF2 protein, human

Identifiers

PMID41614303
PMCPMC12856215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.